According to a pre-event survey by UBM Live ahead of the CPhI Worldwide 2012 meeting, 97% of visitors expect sales to increase or stay the same over the next 12 months (up from 90% over the last 12 months), and 90% rate their business opportunity in the global pharmaceutical market positively.
Attendees expect pockets of innovation to positively impact their overall business including GMP certification (64.8%), the rise in generics (58.6%), the move toward outsourcing (53.4%) and supply chain security (50.4%). The visitors polled represent pharmaceutical buyers who plan to attend CPhI Worldwide, set for October 9-11 at the Feria de Madrid in Spain. CPhI and co-located events ICSE, InnoPack and P-MEC Europe host 2,200 suppliers offering ingredients, finished dosage, contract services, equipment, and packaging.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze